Prevalence of rosacea in transgender and gender-diverse populations: a retrospective cohort study-Reference-Cited by-同舟云学术

Prevalence of rosacea in transgender and gender-diverse populations: a retrospective cohort study

Published:2022-11-09 Issue:2 Volume:188 Page:304-306
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Sanz Jessika¹²³^ORCID,Gao Julia L⁴,King Dana S¹,Modest Anna M⁵⁶^ORCID,Dommasch Erica D¹²⁶

Affiliation:

1. The Fenway Institute, Fenway Health , Boston, MA , USA

2. Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA

3. New York Institute College of Osteopathic Medicine , Jonesboro, AR , USA

4. George Washington University School of Medicine & Health Sciences , Washington, DC , USA

5. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA and

6. Harvard Medical School , Boston, MA , USA

Abstract

Hormones have been shown to affect the pathophysiology of rosacea, however, the prevalence of rosacea in transgender and gender diverse (TGD) patients on gender affirming hormone therapy (GAHT) has never been studied. Our retrospective cohort study showed a significantly decreased prevalence TGD patients on feminizing GAHT compared to cisgender men, women, and TGD not on GAHT. Our results suggest that estrogen and/or anti-androgenetic agents may play a protective role in the development or course of rosacea.

Funder

Beth Israel Deaconess Medical Center

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljac041/48343361/ljac041.pdf

Reference6 articles.

1. Effect of oral inhibitors of ovulation in treatment of rosacea and dermatitis perioralis in women;Spirov;Australas J Dermatol,1971

2. Oral spironolactone therapy in male patients with rosacea;Aizawa;J Dermatol,1992

3. Spironolactone may reduce the risk of incident rosacea;Spoendlin;J Invest Dermatol,2013

4. Experiences in dermatology with various contraceptives containing gestagen;Vankos;Gyogyszereink,1972

5. Prescribing for transgender patients;Tomlins;Aust Prescr,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatological aspects of gender affirming medical treatment in transgender and gender diverse people: a systematic review;International Journal of Transgender Health;2024-07-11

2. Clinical characteristics of rosacea in perimenopausal women;Skin Research and Technology;2024-01